Skip to main content

TEVA 7166 Pill - white & yellow capsule/oblong, 22mm

Pill with imprint TEVA 7166 is White & Yellow, Capsule/Oblong and has been identified as Celecoxib 200 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Celecoxib is used in the treatment of Ankylosing Spondylitis; Osteoarthritis; Chronic Pain; Juvenile Rheumatoid Arthritis; Familial Adenomatous Polyposis and belongs to the drug class cox-2 inhibitors. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Celecoxib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7166

Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166
Celecoxib 200 mg TEVA 7166

Celecoxib

Imprint
TEVA 7166
Strength
200 mg
Color
White & Yellow
Size
22.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cox-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA Inc
Inactive Ingredients
ferrosoferric oxide, gelatin, mannitol, povidone k30, propylene glycol, shellac, sodium lauryl sulfate, sodium stearyl fumarate, titanium dioxide, D&C Red No. 33, D&C Yellow No. 10

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7166 (Discontinued) Teva Pharmaceuticals USA, Inc.
42291-0194 (Discontinued) AvKare, Inc.
68084-0976 (Discontinued) Amerisource Health Services
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer